USFDA retains OAI status for Indoco’s Goa Plant

24 Apr 2019 Evaluate

The United States Food and Drug Administration (USFDA) has retained the Official Action Indicated (OAI) status for Goa Plant - I (Finished Dosages Facility) of Indoco Remedies. The facility was inspected by the USFDA in January 2019. The plant currently supplies against one approved ANDA and has four ANDAs pending for approval.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

240.70 -4.55 (-1.86%)
17-Dec-2025 15:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.00
Dr. Reddys Lab 1272.55
Cipla 1496.30
Zydus Lifesciences 917.95
Lupin 2111.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×